Air India plane crash death toll rises to 270
The London-bound aircraft crashed into a residential area shortly after take-off killing all but one of the 242 passengers, a 40-year-old British man.
Officials have also been trying to establish how many people were killed on the ground and have been continuing the slow process of matching DNA samples to confirm the victims' identities.
Vigils honouring the dead have taken place across India and the UK.
India's Aircraft Accident Investigation Bureau (AAIB) is leading the inquiry into the cause of the crash, helped by teams from the US and UK.
On Friday, a black box was found at the site of the crash which India's civil aviation minister, Ram Mohan Naidu Kinjarapu, said would "significantly aid the inquiry" into the disaster.
Less than 60 seconds after leaving Ahmedabad's Sardar Vallabhbhai Patel International Airport, the plane lost altitude and crashed into a building that was used as doctors' accommodation at the BJ Medical College and Civil Hospital.
On Saturday, the President of the Junior Doctors' Association of the college, Dr Dhaval Gameti, confirmed the hospital had received the bodies of 270 victims.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Reliance enters joint venture with Naturedge Beverages
Reliance Consumer Products, the consumer brands division of India's Reliance Industries has acquired a majority stake in a joint venture with functional drinks maker Naturedge Beverages. Financial terms of the transaction were not disclosed. In a statement, Reliance's consumer arm said the joint venture will look to offer consumers a selection of "herbal-natural beverages", bolstering its 'presence as a total beverage company'. The group added that the healthy functional beverage sector offers a 'large and rapidly expanding opportunity' fuelled by "strong" consumer movement towards "healthier, natural alternatives". In the same statement, Ketan Mody, executive director of Reliance Consumer Products, said the venture 'strengthens our beverage portfolio with the addition of health-focused functional drinks, inspired by Ayurveda." Naturedge Beverages, founded in 2018 by Siddhesh Sharma of the Baidyanath Group, specialises in better-for-you drinks inspired by the holisitic medicine system Ayuverda. Mody added: 'Within a very short span of time, Shunya has gained wide popularity among health-conscious consumers' and 'also fits perfectly' with the company's vision. Naturedge's flagship product, Shunya, is a zero-sugar, zero-calorie beverage infused with Indian herbs such as Ashwagandha and Brahmi. The business also makes ready-to-drink functional shots under the Armr brand. Commenting on the deal, co-founder Sharma said: 'The partnership with RCPL is a testament of Shunya's rapidly growing acceptability among consumers. With our visions aligned on turning Shunya into a pan-India brand that caters to consumers love for herbal-natural functional beverages that are refreshing and fun-filled at the same time, this is a win-win for us." The joint venture will enable the Shunya brand to be available to consumers across the country using Reliance's "wide network of distribution and supply chain", Sharma added. In July, Reliance Industries reportedly announced plans to set up a new subsidiary for its consumer-facing brands. According to a report from India's Economic Times at the time, Reliance Industries aimed to draw a new pool of investors to its FMCG portfolio by presenting the business as a standalone entity, instead of keeping it embedded within its broader retail operations. At the time Reuters said India's National Company Law Tribunal had approved the restructuring exercise, according to a document cited by the news agency and dated 25 June. 'This is a large business by itself requiring specialised and focused attention, expertise and different skill sets as compared to retail business,' Reliance Industries said in its request for approval to the Tribunal, the document quoted by Reuters said. It added: 'This business also entails large capital investments on an on-going basis and can attract a different set of investors.' The creation of the new subsidiary business unit will involve the transfer of the company's consumer brands from its existing retail arm, according to Reuters, which baked the observation made by the Economic Times. "Reliance enters joint venture with Naturedge Beverages" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
a day ago
- Yahoo
Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS
Data on Alcon's products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained performance of Vivity including in patients with common mild comorbidities Alcon's Symposia on new generation phaco and vitrectomy system will discuss new data on anterior chamber stability during cataract surgery performed at more physiologic IOP AHMEDABAD, India, August 19, 2025--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. APACRS will be held at Mahatma Mandir Convention and Exhibition Centre (MMCEC) in Ahmedabad, India from August 21-23, 2025. The company will showcase four symposia, lead 10 medical affairs scientific exchange presentations, and offer a hands-on experience zone at booth #A1). These comprehensive activities combined with new data underscore Alcon's commitment to generating meaningful scientific evidence on the safety and efficacy of its innovations. Massimo Cerrone, Vice President, Surgical for Alcon Asia Pacific, said, "APACRS brings together leading experts and their insights from across the region, creating an ideal environment to engage in critical topics such as the evolving needs of cataract care in the ageing population. Through a dynamic agenda, surgeons can explore Alcon's latest innovations and their value through clinical evidence, real-world insights, and peer experience across Asia-Pacific." Key data being presented at this year's event Alcon's Vivity® is an extensively studied Extended Depth of Focus (EDOF) intraocular lens (IOL) in special populations with different co-morbidities, supported by over 10 clinical studies involving more than 700 patients. Among these is a prospective study titled, 'To Evaluate The Visual Outcomes and Patient Satisfaction After Bilateral Vivity® IOL Implantation in Patients with Mild Irregular Astigmatism.' Conducted by Dr. Ashvin Agarwal, analyses reinforce patient satisfaction outcomes with Vivity in this specific cohort. This will be shared as an e-poster. On the cataract equipment side, Dr. Shail Vasavada of Raghudeep Eye Hospital, will present a prospective, randomized, single masked, single-center study titled, 'Retinal Perfusion During Cataract Surgery With Varying Intraocular Pressure in Comorbid Eyes.' Data underlines the benefits of performing cataract surgery at more physiologic IOP in patients with diabetic retinopathy. (Friday, 22 August 2025, 15:20pm-15:25pm, at FP3-15, Seminar Hall 2, MMCEC) Amar Vyas, Country Head, Alcon India said, "We are excited that India is hosting APACRS for the second time. The event is an ideal platform to showcase our breakthrough technologies like the Advanced Technology IOL portfolio and UNITY VCS/CS, and foster meaningful exchange amongst ECPs. As cataract procedures rise, it's critical that advanced technologies are both clinically proven across diverse patient populations and accessible to those who need them. We remain committed to empowering surgeons with science-backed solutions that elevate surgical precision and patient outcomes." During the meeting, Alcon will host four symposia; interested participants can learn more and register at Alcon UNITY® VCS Launch Symposium - Ready to explore the future of Surgical Innovation? Experience Superior Efficiency - Unity® VCS, held exclusively for India on Thursday, 21 August 2025, 12:45pm to 13:40pm IST at Seminar Hall 2, Ground Floor. This session will mark the official introduction of UNITY VCS (Vitreoretinal Cataract System) and UNITY CS (Cataract System), Alcon's next-generation Phaco/Vit platform, to the Indian market. Alcon IOL Symposium - Stay Ahead with the Clareon® Collection on Friday, 22 August 2025,12:30pm to 13:25pm IST at Convention Hall 2, Ground Floor. This session will cover the Clareon Collection as a comprehensive IOL portfolio, discuss optical differentiation and performance of newer EDOF IOLs, and highlight the role of digital image guidance in toric correction. Alcon Surgical Video Symposium - Experience Extraordinary Phaco & VR Surgery with the NEW UNITY® VCS by Alcon on Saturday, 23 August 2025, 12:00pm to 12:55pm IST at Convention Hall 2, Ground Floor. Through live discussion and videos, leading surgeons will showcase their experience with UNITY VCS in cataract and vitreoretinal procedures. Alcon Global Medical Affairs symposium - Vivity IOL, A True EDOF IOL with Proven Real-World Performance on Saturday, 23 August 2025, 13:00pm to 14:00pm IST at Seminar Hall 2, Ground Floor. The session, moderated by Dr. Vaishali Vasavada, will review meaningful real-world evidence supporting the use of Vivity IOL in special populations. To reserve your seat, visit For information on Alcon's presence at APACRS 2025, including the symposia and exhibition taking place at booth #A1, please visit the company's event page. The site will be updated following the event with on-demand content, such as archives of the symposia. Join the conversation on social platforms with the hashtag #APACRS2025 #Alcon. About the AcrySof IQ Vivity IOL The Wavefront Shaping AcrySof® IQ Vivity Extended Vision Posterior Chamber Intraocular Lens Model DFT015 (referred to as AcrySof IQ Vivity IOL) is a UV-absorbing and blue light-filtering foldable intraocular lens (IOL). This IOL, compared to a monofocal IOL, provides an extended range of vision from distance to near without increasing the incidence of visual disturbances.1 About UNITY VCS and UNITY CS The UNITY VCS (Vitreoretinal Cataract System) console, when used with compatible devices, is indicated for use during anterior segment (i.e. phacoemulsification and removal of cataracts) and posterior segment (i.e. vitreoretinal) ophthalmic surgery. In addition, with the optional laser this system is indicated for photocoagulation (i.e. vitreoretinal and macular pathologies), iridotomy and trabeculoplasty procedures. The UNITY CS (Cataract System) console, when used with compatible devices, is indicated for use during anterior segment (i.e. phacoemulsification and removal of cataracts) ophthalmic surgery.2 About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at The content of this press release is intended for use by healthcare professionals only, including Registered Medical Practitioners, hospitals, or laboratories, and its use in any publication is subject to applicable local laws and regulations. References Acrysof IQ Vivity Extended Vision IOL Global Directions for Use [REF-22568] UNITY VCS and CS User Manual 2024 [REF-27652] Connect with us on: Facebook LinkedIn View source version on Contacts Media Relations MinSeo +821063849533 Pooja 9884646793
Yahoo
a day ago
- Yahoo
Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS
Data on Alcon's products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained performance of Vivity including in patients with common mild comorbidities Alcon's Symposia on new generation phaco and vitrectomy system will discuss new data on anterior chamber stability during cataract surgery performed at more physiologic IOP AHMEDABAD, India, August 19, 2025--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. APACRS will be held at Mahatma Mandir Convention and Exhibition Centre (MMCEC) in Ahmedabad, India from August 21-23, 2025. The company will showcase four symposia, lead 10 medical affairs scientific exchange presentations, and offer a hands-on experience zone at booth #A1). These comprehensive activities combined with new data underscore Alcon's commitment to generating meaningful scientific evidence on the safety and efficacy of its innovations. Massimo Cerrone, Vice President, Surgical for Alcon Asia Pacific, said, "APACRS brings together leading experts and their insights from across the region, creating an ideal environment to engage in critical topics such as the evolving needs of cataract care in the ageing population. Through a dynamic agenda, surgeons can explore Alcon's latest innovations and their value through clinical evidence, real-world insights, and peer experience across Asia-Pacific." Key data being presented at this year's event Alcon's Vivity® is an extensively studied Extended Depth of Focus (EDOF) intraocular lens (IOL) in special populations with different co-morbidities, supported by over 10 clinical studies involving more than 700 patients. Among these is a prospective study titled, 'To Evaluate The Visual Outcomes and Patient Satisfaction After Bilateral Vivity® IOL Implantation in Patients with Mild Irregular Astigmatism.' Conducted by Dr. Ashvin Agarwal, analyses reinforce patient satisfaction outcomes with Vivity in this specific cohort. This will be shared as an e-poster. On the cataract equipment side, Dr. Shail Vasavada of Raghudeep Eye Hospital, will present a prospective, randomized, single masked, single-center study titled, 'Retinal Perfusion During Cataract Surgery With Varying Intraocular Pressure in Comorbid Eyes.' Data underlines the benefits of performing cataract surgery at more physiologic IOP in patients with diabetic retinopathy. (Friday, 22 August 2025, 15:20pm-15:25pm, at FP3-15, Seminar Hall 2, MMCEC) Amar Vyas, Country Head, Alcon India said, "We are excited that India is hosting APACRS for the second time. The event is an ideal platform to showcase our breakthrough technologies like the Advanced Technology IOL portfolio and UNITY VCS/CS, and foster meaningful exchange amongst ECPs. As cataract procedures rise, it's critical that advanced technologies are both clinically proven across diverse patient populations and accessible to those who need them. We remain committed to empowering surgeons with science-backed solutions that elevate surgical precision and patient outcomes." During the meeting, Alcon will host four symposia; interested participants can learn more and register at Alcon UNITY® VCS Launch Symposium - Ready to explore the future of Surgical Innovation? Experience Superior Efficiency - Unity® VCS, held exclusively for India on Thursday, 21 August 2025, 12:45pm to 13:40pm IST at Seminar Hall 2, Ground Floor. This session will mark the official introduction of UNITY VCS (Vitreoretinal Cataract System) and UNITY CS (Cataract System), Alcon's next-generation Phaco/Vit platform, to the Indian market. Alcon IOL Symposium - Stay Ahead with the Clareon® Collection on Friday, 22 August 2025,12:30pm to 13:25pm IST at Convention Hall 2, Ground Floor. This session will cover the Clareon Collection as a comprehensive IOL portfolio, discuss optical differentiation and performance of newer EDOF IOLs, and highlight the role of digital image guidance in toric correction. Alcon Surgical Video Symposium - Experience Extraordinary Phaco & VR Surgery with the NEW UNITY® VCS by Alcon on Saturday, 23 August 2025, 12:00pm to 12:55pm IST at Convention Hall 2, Ground Floor. Through live discussion and videos, leading surgeons will showcase their experience with UNITY VCS in cataract and vitreoretinal procedures. Alcon Global Medical Affairs symposium - Vivity IOL, A True EDOF IOL with Proven Real-World Performance on Saturday, 23 August 2025, 13:00pm to 14:00pm IST at Seminar Hall 2, Ground Floor. The session, moderated by Dr. Vaishali Vasavada, will review meaningful real-world evidence supporting the use of Vivity IOL in special populations. To reserve your seat, visit For information on Alcon's presence at APACRS 2025, including the symposia and exhibition taking place at booth #A1, please visit the company's event page. The site will be updated following the event with on-demand content, such as archives of the symposia. Join the conversation on social platforms with the hashtag #APACRS2025 #Alcon. About the AcrySof IQ Vivity IOL The Wavefront Shaping AcrySof® IQ Vivity Extended Vision Posterior Chamber Intraocular Lens Model DFT015 (referred to as AcrySof IQ Vivity IOL) is a UV-absorbing and blue light-filtering foldable intraocular lens (IOL). This IOL, compared to a monofocal IOL, provides an extended range of vision from distance to near without increasing the incidence of visual disturbances.1 About UNITY VCS and UNITY CS The UNITY VCS (Vitreoretinal Cataract System) console, when used with compatible devices, is indicated for use during anterior segment (i.e. phacoemulsification and removal of cataracts) and posterior segment (i.e. vitreoretinal) ophthalmic surgery. In addition, with the optional laser this system is indicated for photocoagulation (i.e. vitreoretinal and macular pathologies), iridotomy and trabeculoplasty procedures. The UNITY CS (Cataract System) console, when used with compatible devices, is indicated for use during anterior segment (i.e. phacoemulsification and removal of cataracts) ophthalmic surgery.2 About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at The content of this press release is intended for use by healthcare professionals only, including Registered Medical Practitioners, hospitals, or laboratories, and its use in any publication is subject to applicable local laws and regulations. References Acrysof IQ Vivity Extended Vision IOL Global Directions for Use [REF-22568] UNITY VCS and CS User Manual 2024 [REF-27652] Connect with us on: Facebook LinkedIn View source version on Contacts Media Relations MinSeo +821063849533 Pooja 9884646793
